Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Tango Therapeutics (TNGX) Return on Invested Capital (2021 - 2025)

Historic Return on Invested Capital for Tango Therapeutics (TNGX) over the last 5 years, with Q3 2025 value amounting to 0.75%.

  • Tango Therapeutics' Return on Invested Capital fell 1600.0% to 0.75% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.75%, marking a year-over-year decrease of 1600.0%. This contributed to the annual value of 0.64% for FY2024, which is 1900.0% down from last year.
  • As of Q3 2025, Tango Therapeutics' Return on Invested Capital stood at 0.75%, which was down 1600.0% from 1.04% recorded in Q2 2025.
  • Over the past 5 years, Tango Therapeutics' Return on Invested Capital peaked at 0.16% during Q4 2021, and registered a low of 8.73% during Q2 2021.
  • For the 5-year period, Tango Therapeutics' Return on Invested Capital averaged around 0.95%, with its median value being 0.49% (2024).
  • Its Return on Invested Capital has fluctuated over the past 5 years, first soared by 84300bps in 2022, then crashed by -5300bps in 2025.
  • Tango Therapeutics' Return on Invested Capital (Quarter) stood at 0.16% in 2021, then plummeted by -158bps to 0.43% in 2022, then dropped by -1bps to 0.43% in 2023, then crashed by -58bps to 0.68% in 2024, then fell by -10bps to 0.75% in 2025.
  • Its Return on Invested Capital stands at 0.75% for Q3 2025, versus 1.04% for Q2 2025 and 0.8% for Q1 2025.